CLINICAL ROLE -
Expert discusses the role of FLT3 inhibitors in the treatment of AML and if benefit from midostaurin in combination with chemotherapy can be predicted.
Advancement in Stem Cell Transplantation: Improving Outcomes for Patients With Blood Cancer
Pharmacy Focus Oncology: Advancements in Hematology and Breast Cancer - ASH and SABCS 2023 Recap
Pirtobrutinib and BTK Inhibitors in the CLL Treatment Landscape
Pharmacy Focus: Oncology Edition - Experts See Promising Future for the Treatment of Acute Lymphoblastic Leukemia
Researchers Develop ADC Combination Therapy to Target TRBC1-Expressed Hematologic Cancers
Study Suggests Patients With Low-Risk CLL May Stop Specialized Follow-Up Visits